Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2008
07/17/2008WO2008084087A2 Dbait and its standalone uses thereof
07/17/2008WO2008083969A2 Differential expression of subgenome specific alleles in cotton and uses thereof
07/17/2008WO2008083949A2 Rna-coded antibody
07/17/2008WO2008083931A1 Use of a tailored recombinases for the treatment of retroviral infections
07/17/2008WO2008083598A1 Transgenic crop being selectively killed, preparation and utilization thereof
07/17/2008WO2008083554A1 Methods for nucleic acid mapping and identification of fine-structural-variations in nucleic acids
07/17/2008WO2008083493A1 Stabilization of cyclic peptide structures
07/17/2008WO2008083456A1 Microsatellite-based fingerprinting system for saccharum complex
07/17/2008WO2008083441A1 Boron transporter
07/17/2008WO2008067560A9 Compositions and methods of sphingosine kinase inhibitors for use thereof in cancer therapy
07/17/2008WO2008065398A3 Evolved orthogonal ribosomes
07/17/2008WO2008064357A9 Nanoparticles for protection of cells from oxidative stress
07/17/2008WO2008057234A9 Modulation of t cell signaling threshold and t cell sensitivity to antigens
07/17/2008WO2008052187A3 Antibodies and immunoconjugates and uses therefor
07/17/2008WO2008047113A3 Ethanol production
07/17/2008WO2008040027A9 Directed differentiation and maturation of stem cell-derived cardiomyocytes
07/17/2008WO2008039974A3 Cancer vaccines and vaccination methods
07/17/2008WO2008032287A3 Regulation of sucrose content and/or cell wall composition in sugarcane
07/17/2008WO2008027534A3 Transgenic plants with enhanced drought-resistance and method for producing the plants
07/17/2008WO2008026015A3 Liposomally encapsulated hybrid adenovirus-semliki forest virus (sfv) vectors carrying rnai constructs and therapeutic genes for use against cancer targets and other diseases
07/17/2008WO2008011431A3 Rna interference mediated inhibition of proprotein convertase subtilisin kexin 9 (pcsk9) gene expression using short interfering nucleic acid (sina)
07/17/2008WO2008010101A3 Antagonist antibody against epha2 for the treatment of cancer
07/17/2008WO2007149657A3 Antifungal polypeptides
07/17/2008WO2007137075A8 Use of non-agrobacterium bacterial species for plant transformation
07/17/2008WO2007095496A3 Selecting and stabilizing dsrna constructs
07/17/2008WO2006002038A3 Immunostimulatory oligonucleotide multimers
07/17/2008WO2001060998A9 Small oligonucleotides with anti-tumor activity
07/17/2008US20080172764 Axmi-004, a delta-endotoxin gene and methods for its use
07/17/2008US20080172763 Nod-Factor Perception
07/17/2008US20080172762 Nucleotide sequences coding insecticidal protein for use in generation of insect resistant plants
07/17/2008US20080172760 Cytokinin Oxidase Promoter from Maize
07/17/2008US20080172759 Transgenic plant comprising expression vector coding genes which confer salinity, drought, temperature, metal, chemical and/or pathogenic resistance
07/17/2008US20080172758 Plant Galactinol Synthase Homologs
07/17/2008US20080172756 Soybean variety 4568207
07/17/2008US20080172755 Soybean variety 4840308
07/17/2008US20080172754 Soybean variety 4256323
07/17/2008US20080172752 Recombinant rodent animal model for identifying modulators for treatment of obesity and eating disorders
07/17/2008US20080171862 Double stranded RNA packaged in liposome for use therapeutic tool in treatment of cell proliferative and viral disorders; Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference
07/17/2008US20080171861 Method and medicament for inhibiting the expression of a given gene
07/17/2008US20080171860 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation
07/17/2008US20080171855 Polyvalent protein complex
07/17/2008US20080171854 Tumor suppressor gene, p47ing3
07/17/2008US20080171851 Generation of artificial binding proteins on the basis of ubiquitin proteins
07/17/2008US20080171719 RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS
07/17/2008US20080171717 Double-Stranded Synthetic Oligonucleotides Useful For Inducing Apoptosis of Osteoclasts For the Treatment of Osteopenic Pathologies
07/17/2008US20080171716 Nucleic acid modulation of toll-like receptor-mediated immune stimulation
07/17/2008US20080171715 Methods and compositions involving mirna and mirna inhibitor molecules
07/17/2008US20080171712 At least two oligonucleotides having modified purine bases, such as deazaguanosines or deaza-adenosines, linked by an alkyl or phenolic diol or triol; vaccines, DNA vaccines; anticarcinogenic, antiallergenic, antiinflammatory agents; bronchodilators
07/17/2008US20080171702 Novel gene and uses therefor
07/17/2008US20080171689 Having an extracellular domain of an FGFR1 polypeptide having an increased sialaytion level for more stability and a Fc fusion partner; antiproliferative, anticarcinogenic, antitumor agents; angiogenesis inhibitors;
07/17/2008US20080171667 Methods and Compositions Involving microRNA
07/17/2008US20080171391 Methods and means for altering fiber characteristics in fiber-producing plants
07/17/2008US20080171390 Adenovirus vectors containing cell status-specific response elements and methods of use thereof
07/17/2008US20080171389 Primer sequences for screening and detection of gene sequences in DNA pools
07/17/2008US20080171374 Recombinant Clan C hydrolase for use in cleaning agents, textile treatment and enhancement of animal feeds; directed protein evolution
07/17/2008US20080171365 Using mutagenic primer to generate modified nucleotide sequences coding for immunoglobulin comprised of variant in light and heavy chain; directed protein evolution
07/17/2008US20080171363 Interferon-alpha polypeptides and conjugates
07/17/2008US20080171362 Polynucleotides Encoding Proteins with Clot-Specific Streptokinase Activity
07/17/2008US20080171361 CAP-Independent Translational Enhancer for Protein Synthesis in Wheat Germ Extract and Transgenic Cereals
07/17/2008US20080171360 Carbohydrate active hydrolase; biomass conversion for biofuels; ethanol production; enhancing feed compositions and food processing
07/17/2008US20080171359 Using transgenic yarrowia as bioreactor for use in production of epoxide hydrolase; generating vicinal diols for use as chemical intermediates for the production of pharmaceuticals, agrochemicals, ferro-electric liquid crystals flavors and fragrances
07/17/2008US20080171358 Expression System
07/17/2008US20080171357 Using escherichia as bioreactor for production of empedobacter or sphingobacterium peptide sequences for use in pharmaceutical and foods
07/17/2008US20080171353 Novel guanosine triphosphate-binding protein-coupled receptor place6002312, its gene, and production and uses thereof
07/17/2008US20080171349 Alzheimer's Disease Secretase, APP Substrates Therefor and Uses Therefor
07/17/2008US20080171339 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
07/17/2008US20080171330 Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
07/17/2008US20080171329 Gel Microdrops in Genetic Analysis
07/17/2008US20080171328 Vertebrate hedgehog polypeptide for use as tools in identifying modulators for use in treatment and prevention of nervous system disorders
07/17/2008US20080171321 QTL controlling Sclerotinia stem ROT resistance in soybean
07/17/2008US20080171315 Homogeneous assay system
07/17/2008US20080171314 Method for controlling the microbiological quality of an aqueous medium and kit therefor
07/17/2008US20080171313 Identifying nucleoside resistant hepatitis b virus based on presence of mutation in polymerase gene
07/17/2008US20080171213 Use of Hydroxypropylated High Amylose Content Potato Starches to Achieve High Kit Numbers
07/17/2008US20080171073 Antibiotic-Sensitive Lactic Acid Bacteria Strains
07/17/2008US20080171066 Non-pathogenic Bacillus spores comprising a polynucleotide sequence encoding a phagosome membrane-rupturing agent; and a polynucleotide sequence encoding a heterologous polypeptide; immunisation and vaccination
07/17/2008US20080171062 Hepatitis B surface antigen (HBsAg); contain heterologous polyepitopes fused to the middle (M) envelope protein; useful in immunogenic compositions and as vaccines; expression vector for the production of virus-like particles comprising fusion proteins and S proteins of hepatitis B virus (HBV)
07/17/2008US20080171058 Compositions and Methods For Synergistic Induction of Antitumor Immunity
07/17/2008US20080171054 Immunoglobulin for use in detection, prevention and treatment of methicillin-resistant staphylococcus aureus (MRSA) infection
07/17/2008US20080171051 Cancer Treatment
07/17/2008US20080171046 Novel proteins and nucleic acids encoding same
07/17/2008US20080171043 Cytotoxin conjugated immunoglobulin specific to tripeptide sequence (N'-Trp-Pro-Ile-C') of carcinoembryonic antigen for use in treatment and prevention of cell proliferative disorders
07/17/2008US20080171042 Using antisense agents to prevent/reduce cell surface glycoprotein expression and treat cell proliferative disorders of prostate gland
07/17/2008US20080171037 Tumor necrosis factor receptor ligand for use in identifying modulators for prevention and treatment of cell proliferative, nervous system, cardiovascular and autoimmune disorders
07/17/2008US20080171036 Using tumor necrosis factor specific immuoglobulin for diagnosis, treatment and prevention of inflammatory, cell proliferative, skin, respiratory system, nervous system and infectious disorders
07/17/2008US20080171035 Mammalian cell membrane proteins; related reagents
07/17/2008US20080171027 Compositions and Methods for Elimination of Unwanted Cells
07/17/2008US20080171026 Using recombinant cells expressing measles virus H glycoprotein to target tumor cells fusion and removal; tissue target therapy
07/17/2008US20080171025 Using histidine and lysine (HK) as carrier sequences in small interfering RNA transfection complex; for use in prevention and treatment of cell proliferative, muscular, blood, respiratory and nervous system disorders
07/17/2008US20080171018 Serotype of adenovirus and uses thereof
07/17/2008DE4393381B4 PTH-Verbindungen mit PTH-ähnlicher Aktivität, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Zusammensetzungen und deren Verwendungen PTH compounds having PTH-like activity, to processes for their preparation, pharmaceutical compositions containing them and their uses
07/17/2008DE102007003148A1 Gentechnisch modifizierte Bakteriophagen, insbesondere zur Bekämpfung von pathogenen Prokaryonten bzw. ihrer pathologischen Wirkung, sowie deren Verwendung und Herstellung Genetically modified bacteriophage, particularly for combating pathogenic prokaryotes and their pathological effects, and their use and production
07/17/2008DE102007003143A1 Neue Alkalische Protease aus Bacillus gibsonii und Wasch- und Reinigungsmittel enthaltend diese neue Alkalische Protease New alkaline protease from Bacillus gibsonii and detergents and cleaning agents containing these novel alkaline protease
07/17/2008CA2675115A1 Lactococcus promoters and uses thereof
07/17/2008CA2675024A1 Stabilization of cyclic peptide structures
07/17/2008CA2675022A1 Adenoviral vector-based malaria vaccines
07/17/2008CA2674715A1 Methods for selecting improved filamentous fungal strains for enzyme production involving temperature and cellulose conditions
07/17/2008CA2674645A1 Fad2 mutants and high oleic acid plants
07/17/2008CA2674493A1 Compositions of and methods of using sulfatases from flavobacterium heparinum
07/17/2008CA2674298A1 Associations of single nucleotide polymorphisms and haplotypes with feed intake and feed efficiency in beef cattle